Skip to main content
Log in

16th Clinical Trials on Alzheimer’s Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters

  • Published:
The Journal of Prevention of Alzheimer's Disease Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Additional information

CTAD / JPAD platform

Do not assume any responsibility for the content of the posters or presentations, we simply select them according to a grid of objective criteria, elaborated by a committee of renowned experts, who leave the authors the full responsibility for their content.

Do not make any judgement on the legal or even more, judicial plans which exceed our competences and do not wish to enter into any exchange on this plan.

Do act as a scientific «platform» and therefore, we are very careful about our neutrality and objectivity.

Do not cope with any cause and do not wish to give any echo to polemics that do not concern us

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

16th Clinical Trials on Alzheimer’s Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters. J Prev Alzheimers Dis 10 (Suppl 1), 56–240 (2023). https://doi.org/10.14283/jpad.2022.130

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.14283/jpad.2022.130

Navigation